Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis

• Christopher Oldmeadow,
• Angela Smith,
• Madeleine Hinwood,
• Danielle Lang,
• Samuel Lees,
• Mathew Dicker,
• Jie En Ku,
• Varun Chaganti,
• Matthew Mew-Sum,
• Nick Wang,
• Wooi Lynn Goon,
• Marc Bevan

Affiliations

Christopher Oldmeadow

Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia

Angela Smith

HNEHealth Libraries, Hunter New England Local Health District, New Lambton, New South Wales, Australia

Madeleine Hinwood

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Danielle Lang

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Samuel Lees

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Mathew Dicker

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Jie En Ku

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Varun Chaganti

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Matthew Mew-Sum

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Nick Wang

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Wooi Lynn Goon

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia

Marc Bevan

School of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales, Australia